Results of our studies indicated that silencing of TGF-β1 in tumor cells in situ exerted a significant effect on tumor fibroblast proliferation, differentiation and expression of protumorigenic growth factors, in particular, MMP9, as well as myofibroblast differentiation. This evidence concerns the gene MMP9 and neoplasm.